Rubella eradication.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 11348695)

Published in Vaccine on May 14, 2001

Authors

S A Plotkin1

Author Affiliations

1: Aventis Pasteur, Wistar Institute, University of Pennsylvania, 4650 Wismer Road, Doylestown, PA 18901, USA.

Articles citing this

Rubella metapopulation dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru. J R Soc Interface (2010) 1.23

Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ (2008) 1.19

The epidemiology of rubella in Mexico: seasonality, stochasticity and regional variation. Epidemiol Infect (2010) 1.17

Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter. J Clin Microbiol (2008) 1.11

Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees. Cytokine (2010) 1.06

Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol (2007) 1.06

Zika virus - reigniting the TORCH. Nat Rev Microbiol (2016) 1.03

Health economics of rubella: a systematic review to assess the value of rubella vaccination. BMC Public Health (2013) 0.91

Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies. Clin Microbiol Rev (2016) 0.90

Analysis of gene expression in fetal and adult cells infected with rubella virus. Virology (2007) 0.90

Congenital rubella infection following rubella outbreak in northern Italy, 2002: need for an effective vaccination programme. Eur J Clin Microbiol Infect Dis (2004) 0.85

Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies. Clin Diagn Lab Immunol (2005) 0.85

Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children. Immunogenetics (2015) 0.76

Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs. Vaccines (Basel) (2015) 0.75

Sensory defects and developmental delay among children with congenital rubella syndrome. Sci Rep (2017) 0.75

Characterization of rubella seronegative females in the zambian blood donor community. Front Public Health (2015) 0.75